-+ 0.00%
-+ 0.00%
-+ 0.00%

Virax Biolabs adjourns shareholder meeting after quorum fails to show

PUBT·08/26/2026 20:33:46
Listen to the news
Virax Biolabs adjourns shareholder meeting after quorum fails to show
  • Virax Biolabs’ Aug. 14 shareholder meeting was delayed due to a lack of quorum, with 6.33% of eligible shares represented.
  • The meeting reconvened on Aug. 21, with 8.94% represented; shareholders present then counted as a quorum under the articles.
  • Investors backed a major authorized share capital increase to 500,000,000 ordinary shares from 2,000,000.
  • A separate special resolution to adopt amended articles to reflect the revised share capital failed to pass.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Virax Biolabs Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-368710), on August 26, 2026, and is solely responsible for the information contained therein.